Indications |
Oral Antispasmodic Adult: 40-80 mg tid. Child: 1-6 yr: 20 mg 3-4 times daiily; >6 yr: 40 mg tid. |
Contraindications |
Severe renal/hepatic/cardiac dysfunction. Porphyria. |
Warnings / Precautions |
Exercise caution in patients with renal/hepatic/cardiac dysfunction. Pregnacy, lactation. |
Adverse Reactions |
Vertigo, nausea, vomiting, dry mouth. |
Drug Interactions |
May attenuate the action of levodopa. Concurrent use of analgesics, antimuscarinics or benzodiazepines. Additive beneficial effect with concurrent use of analgesics, antimuscarinics or benzodiazepines. See Below for More drotaverine Drug Interactions |
Mechanism of Actions |
Drotaverine has antispasmodic effect mediated via inhibition of phosphodiesterase-IV, specific for smooth muscle. It has a rapid and direct action on the smooth muscle. It acts to correct cyclic AMP and Ca imbalance at the spastic site, thereby relieving smooth muscle spasm and pain. |
Administration |
May be taken with or without food. |
ATC Classification |
A03AD02 - drotaverine ; Belongs to the class of papaverine and derivatives. Used in the treatment of functional bowel disorders. |
Available As |
|
Drotaverine
Post Review about Drotaverine Click here to cancel reply.
Drotaverine Containing Brands
Drotaverine is used in following diseases
Drug - Drug Interactions of Drotaverine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.